nodes	percent_of_prediction	percent_of_DWPC	metapath
Perflutren—Feeling abnormal—Dactinomycin—sarcoma	0.00216	0.00216	CcSEcCtD
Perflutren—Gastrointestinal pain—Thiotepa—sarcoma	0.00216	0.00216	CcSEcCtD
Perflutren—Ill-defined disorder—Etoposide—sarcoma	0.00215	0.00215	CcSEcCtD
Perflutren—Gastrointestinal pain—Dactinomycin—sarcoma	0.00214	0.00214	CcSEcCtD
Perflutren—Hot flush—Doxorubicin—sarcoma	0.00214	0.00214	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Vincristine—sarcoma	0.00213	0.00213	CcSEcCtD
Perflutren—Hypotension—Mitoxantrone—sarcoma	0.00213	0.00213	CcSEcCtD
Perflutren—Menopausal symptoms—Doxorubicin—sarcoma	0.00212	0.00212	CcSEcCtD
Perflutren—Paraesthesia—Vincristine—sarcoma	0.0021	0.0021	CcSEcCtD
Perflutren—Urticaria—Thiotepa—sarcoma	0.00209	0.00209	CcSEcCtD
Perflutren—Malaise—Etoposide—sarcoma	0.00209	0.00209	CcSEcCtD
Perflutren—Face oedema—Epirubicin—sarcoma	0.00208	0.00208	CcSEcCtD
Perflutren—Vertigo—Etoposide—sarcoma	0.00208	0.00208	CcSEcCtD
Perflutren—Abdominal pain—Thiotepa—sarcoma	0.00208	0.00208	CcSEcCtD
Perflutren—Body temperature increased—Thiotepa—sarcoma	0.00208	0.00208	CcSEcCtD
Perflutren—Leukopenia—Etoposide—sarcoma	0.00208	0.00208	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00207	0.00207	CcSEcCtD
Perflutren—Abdominal pain—Dactinomycin—sarcoma	0.00207	0.00207	CcSEcCtD
Perflutren—Body temperature increased—Dactinomycin—sarcoma	0.00207	0.00207	CcSEcCtD
Perflutren—Anaphylactoid reaction—Doxorubicin—sarcoma	0.00206	0.00206	CcSEcCtD
Perflutren—Cardiac arrest—Epirubicin—sarcoma	0.00205	0.00205	CcSEcCtD
Perflutren—Paraesthesia—Mitoxantrone—sarcoma	0.00204	0.00204	CcSEcCtD
Perflutren—Loss of consciousness—Etoposide—sarcoma	0.00204	0.00204	CcSEcCtD
Perflutren—Dyspnoea—Mitoxantrone—sarcoma	0.00203	0.00203	CcSEcCtD
Perflutren—Cough—Etoposide—sarcoma	0.00202	0.00202	CcSEcCtD
Perflutren—Gastrointestinal disorder—Vincristine—sarcoma	0.00202	0.00202	CcSEcCtD
Perflutren—Fatigue—Vincristine—sarcoma	0.00202	0.00202	CcSEcCtD
Perflutren—Convulsion—Etoposide—sarcoma	0.00201	0.00201	CcSEcCtD
Perflutren—Dyspepsia—Mitoxantrone—sarcoma	0.002	0.002	CcSEcCtD
Perflutren—Hypertension—Etoposide—sarcoma	0.002	0.002	CcSEcCtD
Perflutren—Pain—Vincristine—sarcoma	0.002	0.002	CcSEcCtD
Perflutren—Dry skin—Epirubicin—sarcoma	0.00198	0.00198	CcSEcCtD
Perflutren—Chest pain—Etoposide—sarcoma	0.00198	0.00198	CcSEcCtD
Perflutren—Fatigue—Mitoxantrone—sarcoma	0.00196	0.00196	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00196	0.00196	CcSEcCtD
Perflutren—Discomfort—Etoposide—sarcoma	0.00195	0.00195	CcSEcCtD
Perflutren—Pain—Mitoxantrone—sarcoma	0.00195	0.00195	CcSEcCtD
Perflutren—Hypersensitivity—Thiotepa—sarcoma	0.00194	0.00194	CcSEcCtD
Perflutren—Face oedema—Doxorubicin—sarcoma	0.00193	0.00193	CcSEcCtD
Perflutren—Hypersensitivity—Dactinomycin—sarcoma	0.00193	0.00193	CcSEcCtD
Perflutren—Gastrointestinal pain—Vincristine—sarcoma	0.00191	0.00191	CcSEcCtD
Perflutren—Cardiac arrest—Doxorubicin—sarcoma	0.0019	0.0019	CcSEcCtD
Perflutren—Anaphylactic shock—Etoposide—sarcoma	0.00189	0.00189	CcSEcCtD
Perflutren—Asthenia—Thiotepa—sarcoma	0.00189	0.00189	CcSEcCtD
Perflutren—Asthenia—Dactinomycin—sarcoma	0.00188	0.00188	CcSEcCtD
Perflutren—Feeling abnormal—Mitoxantrone—sarcoma	0.00188	0.00188	CcSEcCtD
Perflutren—Pruritus—Thiotepa—sarcoma	0.00186	0.00186	CcSEcCtD
Perflutren—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00186	0.00186	CcSEcCtD
Perflutren—Tachycardia—Etoposide—sarcoma	0.00185	0.00185	CcSEcCtD
Perflutren—Eosinophilia—Epirubicin—sarcoma	0.00185	0.00185	CcSEcCtD
Perflutren—Abdominal pain—Vincristine—sarcoma	0.00185	0.00185	CcSEcCtD
Perflutren—Body temperature increased—Vincristine—sarcoma	0.00185	0.00185	CcSEcCtD
Perflutren—Skin disorder—Etoposide—sarcoma	0.00184	0.00184	CcSEcCtD
Perflutren—Dry skin—Doxorubicin—sarcoma	0.00183	0.00183	CcSEcCtD
Perflutren—Hyperhidrosis—Etoposide—sarcoma	0.00183	0.00183	CcSEcCtD
Perflutren—Urticaria—Mitoxantrone—sarcoma	0.00181	0.00181	CcSEcCtD
Perflutren—Diarrhoea—Thiotepa—sarcoma	0.0018	0.0018	CcSEcCtD
Perflutren—Body temperature increased—Mitoxantrone—sarcoma	0.0018	0.0018	CcSEcCtD
Perflutren—Abdominal pain—Mitoxantrone—sarcoma	0.0018	0.0018	CcSEcCtD
Perflutren—Diarrhoea—Dactinomycin—sarcoma	0.00179	0.00179	CcSEcCtD
Perflutren—Hypotension—Etoposide—sarcoma	0.00177	0.00177	CcSEcCtD
Perflutren—Dizziness—Thiotepa—sarcoma	0.00174	0.00174	CcSEcCtD
Perflutren—Hypersensitivity—Vincristine—sarcoma	0.00172	0.00172	CcSEcCtD
Perflutren—Eosinophilia—Doxorubicin—sarcoma	0.00171	0.00171	CcSEcCtD
Perflutren—Paraesthesia—Etoposide—sarcoma	0.0017	0.0017	CcSEcCtD
Perflutren—Dyspnoea—Etoposide—sarcoma	0.00169	0.00169	CcSEcCtD
Perflutren—Hypersensitivity—Mitoxantrone—sarcoma	0.00168	0.00168	CcSEcCtD
Perflutren—Asthenia—Vincristine—sarcoma	0.00168	0.00168	CcSEcCtD
Perflutren—Vomiting—Thiotepa—sarcoma	0.00168	0.00168	CcSEcCtD
Perflutren—Vomiting—Dactinomycin—sarcoma	0.00166	0.00166	CcSEcCtD
Perflutren—Rash—Thiotepa—sarcoma	0.00166	0.00166	CcSEcCtD
Perflutren—Dermatitis—Thiotepa—sarcoma	0.00166	0.00166	CcSEcCtD
Perflutren—Headache—Thiotepa—sarcoma	0.00165	0.00165	CcSEcCtD
Perflutren—Rash—Dactinomycin—sarcoma	0.00165	0.00165	CcSEcCtD
Perflutren—Gastrointestinal disorder—Etoposide—sarcoma	0.00163	0.00163	CcSEcCtD
Perflutren—Asthenia—Mitoxantrone—sarcoma	0.00163	0.00163	CcSEcCtD
Perflutren—Fatigue—Etoposide—sarcoma	0.00163	0.00163	CcSEcCtD
Perflutren—Neuropathy peripheral—Epirubicin—sarcoma	0.00163	0.00163	CcSEcCtD
Perflutren—Pain—Etoposide—sarcoma	0.00162	0.00162	CcSEcCtD
Perflutren—Conjunctivitis—Epirubicin—sarcoma	0.00162	0.00162	CcSEcCtD
Perflutren—Diarrhoea—Vincristine—sarcoma	0.0016	0.0016	CcSEcCtD
Perflutren—Nausea—Thiotepa—sarcoma	0.00157	0.00157	CcSEcCtD
Perflutren—Feeling abnormal—Etoposide—sarcoma	0.00156	0.00156	CcSEcCtD
Perflutren—Diarrhoea—Mitoxantrone—sarcoma	0.00156	0.00156	CcSEcCtD
Perflutren—Nausea—Dactinomycin—sarcoma	0.00155	0.00155	CcSEcCtD
Perflutren—Gastrointestinal pain—Etoposide—sarcoma	0.00155	0.00155	CcSEcCtD
Perflutren—Dizziness—Vincristine—sarcoma	0.00155	0.00155	CcSEcCtD
Perflutren—Bradycardia—Epirubicin—sarcoma	0.00152	0.00152	CcSEcCtD
Perflutren—Neuropathy peripheral—Doxorubicin—sarcoma	0.00151	0.00151	CcSEcCtD
Perflutren—Urticaria—Etoposide—sarcoma	0.0015	0.0015	CcSEcCtD
Perflutren—Haemoglobin—Epirubicin—sarcoma	0.0015	0.0015	CcSEcCtD
Perflutren—Rhinitis—Epirubicin—sarcoma	0.0015	0.0015	CcSEcCtD
Perflutren—Body temperature increased—Etoposide—sarcoma	0.0015	0.0015	CcSEcCtD
Perflutren—Abdominal pain—Etoposide—sarcoma	0.0015	0.0015	CcSEcCtD
Perflutren—Conjunctivitis—Doxorubicin—sarcoma	0.0015	0.0015	CcSEcCtD
Perflutren—Haemorrhage—Epirubicin—sarcoma	0.00149	0.00149	CcSEcCtD
Perflutren—Hypoaesthesia—Epirubicin—sarcoma	0.00149	0.00149	CcSEcCtD
Perflutren—Vomiting—Vincristine—sarcoma	0.00149	0.00149	CcSEcCtD
Perflutren—Pharyngitis—Epirubicin—sarcoma	0.00148	0.00148	CcSEcCtD
Perflutren—Rash—Vincristine—sarcoma	0.00147	0.00147	CcSEcCtD
Perflutren—Dermatitis—Vincristine—sarcoma	0.00147	0.00147	CcSEcCtD
Perflutren—Connective tissue disorder—Epirubicin—sarcoma	0.00147	0.00147	CcSEcCtD
Perflutren—Headache—Vincristine—sarcoma	0.00146	0.00146	CcSEcCtD
Perflutren—Vomiting—Mitoxantrone—sarcoma	0.00145	0.00145	CcSEcCtD
Perflutren—Visual impairment—Epirubicin—sarcoma	0.00144	0.00144	CcSEcCtD
Perflutren—Rash—Mitoxantrone—sarcoma	0.00144	0.00144	CcSEcCtD
Perflutren—Dermatitis—Mitoxantrone—sarcoma	0.00143	0.00143	CcSEcCtD
Perflutren—Headache—Mitoxantrone—sarcoma	0.00143	0.00143	CcSEcCtD
Perflutren—Bradycardia—Doxorubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Perflutren—Eye disorder—Epirubicin—sarcoma	0.0014	0.0014	CcSEcCtD
Perflutren—Hypersensitivity—Etoposide—sarcoma	0.0014	0.0014	CcSEcCtD
Perflutren—Tinnitus—Epirubicin—sarcoma	0.00139	0.00139	CcSEcCtD
Perflutren—Haemoglobin—Doxorubicin—sarcoma	0.00139	0.00139	CcSEcCtD
Perflutren—Nausea—Vincristine—sarcoma	0.00139	0.00139	CcSEcCtD
Perflutren—Flushing—Epirubicin—sarcoma	0.00139	0.00139	CcSEcCtD
Perflutren—Cardiac disorder—Epirubicin—sarcoma	0.00139	0.00139	CcSEcCtD
Perflutren—Rhinitis—Doxorubicin—sarcoma	0.00139	0.00139	CcSEcCtD
Perflutren—Haemorrhage—Doxorubicin—sarcoma	0.00138	0.00138	CcSEcCtD
Perflutren—Hypoaesthesia—Doxorubicin—sarcoma	0.00138	0.00138	CcSEcCtD
Perflutren—Pharyngitis—Doxorubicin—sarcoma	0.00137	0.00137	CcSEcCtD
Perflutren—Asthenia—Etoposide—sarcoma	0.00136	0.00136	CcSEcCtD
Perflutren—Connective tissue disorder—Doxorubicin—sarcoma	0.00136	0.00136	CcSEcCtD
Perflutren—Angiopathy—Epirubicin—sarcoma	0.00136	0.00136	CcSEcCtD
Perflutren—Nausea—Mitoxantrone—sarcoma	0.00135	0.00135	CcSEcCtD
Perflutren—Immune system disorder—Epirubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Perflutren—Mediastinal disorder—Epirubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Perflutren—Chills—Epirubicin—sarcoma	0.00134	0.00134	CcSEcCtD
Perflutren—Pruritus—Etoposide—sarcoma	0.00134	0.00134	CcSEcCtD
Perflutren—Arrhythmia—Epirubicin—sarcoma	0.00133	0.00133	CcSEcCtD
Perflutren—Visual impairment—Doxorubicin—sarcoma	0.00133	0.00133	CcSEcCtD
Perflutren—Erythema—Epirubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Perflutren—Diarrhoea—Etoposide—sarcoma	0.0013	0.0013	CcSEcCtD
Perflutren—Eye disorder—Doxorubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Perflutren—Tinnitus—Doxorubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Perflutren—Flushing—Doxorubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Perflutren—Cardiac disorder—Doxorubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Perflutren—Dysgeusia—Epirubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Perflutren—Back pain—Epirubicin—sarcoma	0.00126	0.00126	CcSEcCtD
Perflutren—Angiopathy—Doxorubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Perflutren—Dizziness—Etoposide—sarcoma	0.00125	0.00125	CcSEcCtD
Perflutren—Muscle spasms—Epirubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Perflutren—Immune system disorder—Doxorubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Perflutren—Mediastinal disorder—Doxorubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Perflutren—Chills—Doxorubicin—sarcoma	0.00124	0.00124	CcSEcCtD
Perflutren—Arrhythmia—Doxorubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Perflutren—Vision blurred—Epirubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Perflutren—Ill-defined disorder—Epirubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Perflutren—Vomiting—Etoposide—sarcoma	0.0012	0.0012	CcSEcCtD
Perflutren—Erythema—Doxorubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Perflutren—Agitation—Epirubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Perflutren—Rash—Etoposide—sarcoma	0.00119	0.00119	CcSEcCtD
Perflutren—Dermatitis—Etoposide—sarcoma	0.00119	0.00119	CcSEcCtD
Perflutren—Headache—Etoposide—sarcoma	0.00119	0.00119	CcSEcCtD
Perflutren—Dysgeusia—Doxorubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Perflutren—Malaise—Epirubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Perflutren—Vertigo—Epirubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Perflutren—Syncope—Epirubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Perflutren—Leukopenia—Epirubicin—sarcoma	0.00116	0.00116	CcSEcCtD
Perflutren—Back pain—Doxorubicin—sarcoma	0.00116	0.00116	CcSEcCtD
Perflutren—Muscle spasms—Doxorubicin—sarcoma	0.00116	0.00116	CcSEcCtD
Perflutren—Palpitations—Epirubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Perflutren—Loss of consciousness—Epirubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Perflutren—Cough—Epirubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Perflutren—Vision blurred—Doxorubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Perflutren—Convulsion—Epirubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Perflutren—Nausea—Etoposide—sarcoma	0.00112	0.00112	CcSEcCtD
Perflutren—Hypertension—Epirubicin—sarcoma	0.00112	0.00112	CcSEcCtD
Perflutren—Ill-defined disorder—Doxorubicin—sarcoma	0.00112	0.00112	CcSEcCtD
Perflutren—Myalgia—Epirubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Perflutren—Arthralgia—Epirubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Perflutren—Chest pain—Epirubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Perflutren—Agitation—Doxorubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Perflutren—Discomfort—Epirubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Perflutren—Malaise—Doxorubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Perflutren—Dry mouth—Epirubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Perflutren—Vertigo—Doxorubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Perflutren—Syncope—Doxorubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Perflutren—Leukopenia—Doxorubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Perflutren—Palpitations—Doxorubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Perflutren—Anaphylactic shock—Epirubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Perflutren—Oedema—Epirubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Perflutren—Loss of consciousness—Doxorubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Perflutren—Cough—Doxorubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Perflutren—Shock—Epirubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Perflutren—Convulsion—Doxorubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Perflutren—Nervous system disorder—Epirubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Perflutren—Hypertension—Doxorubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Perflutren—Tachycardia—Epirubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Perflutren—Skin disorder—Epirubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Perflutren—Hyperhidrosis—Epirubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Perflutren—Myalgia—Doxorubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Perflutren—Arthralgia—Doxorubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Perflutren—Chest pain—Doxorubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Perflutren—Discomfort—Doxorubicin—sarcoma	0.00101	0.00101	CcSEcCtD
Perflutren—Dry mouth—Doxorubicin—sarcoma	0.001	0.001	CcSEcCtD
Perflutren—Hypotension—Epirubicin—sarcoma	0.000992	0.000992	CcSEcCtD
Perflutren—Anaphylactic shock—Doxorubicin—sarcoma	0.000982	0.000982	CcSEcCtD
Perflutren—Oedema—Doxorubicin—sarcoma	0.000982	0.000982	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000967	0.000967	CcSEcCtD
Perflutren—Shock—Doxorubicin—sarcoma	0.000966	0.000966	CcSEcCtD
Perflutren—Nervous system disorder—Doxorubicin—sarcoma	0.000963	0.000963	CcSEcCtD
Perflutren—Tachycardia—Doxorubicin—sarcoma	0.000958	0.000958	CcSEcCtD
Perflutren—Skin disorder—Doxorubicin—sarcoma	0.000954	0.000954	CcSEcCtD
Perflutren—Paraesthesia—Epirubicin—sarcoma	0.000953	0.000953	CcSEcCtD
Perflutren—Hyperhidrosis—Doxorubicin—sarcoma	0.000949	0.000949	CcSEcCtD
Perflutren—Dyspnoea—Epirubicin—sarcoma	0.000946	0.000946	CcSEcCtD
Perflutren—Dyspepsia—Epirubicin—sarcoma	0.000934	0.000934	CcSEcCtD
Perflutren—Hypotension—Doxorubicin—sarcoma	0.000918	0.000918	CcSEcCtD
Perflutren—Gastrointestinal disorder—Epirubicin—sarcoma	0.000916	0.000916	CcSEcCtD
Perflutren—Fatigue—Epirubicin—sarcoma	0.000915	0.000915	CcSEcCtD
Perflutren—Pain—Epirubicin—sarcoma	0.000908	0.000908	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000895	0.000895	CcSEcCtD
Perflutren—Paraesthesia—Doxorubicin—sarcoma	0.000882	0.000882	CcSEcCtD
Perflutren—Dyspnoea—Doxorubicin—sarcoma	0.000876	0.000876	CcSEcCtD
Perflutren—Feeling abnormal—Epirubicin—sarcoma	0.000875	0.000875	CcSEcCtD
Perflutren—Gastrointestinal pain—Epirubicin—sarcoma	0.000868	0.000868	CcSEcCtD
Perflutren—Dyspepsia—Doxorubicin—sarcoma	0.000864	0.000864	CcSEcCtD
Perflutren—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000848	0.000848	CcSEcCtD
Perflutren—Fatigue—Doxorubicin—sarcoma	0.000847	0.000847	CcSEcCtD
Perflutren—Urticaria—Epirubicin—sarcoma	0.000843	0.000843	CcSEcCtD
Perflutren—Pain—Doxorubicin—sarcoma	0.00084	0.00084	CcSEcCtD
Perflutren—Abdominal pain—Epirubicin—sarcoma	0.000839	0.000839	CcSEcCtD
Perflutren—Body temperature increased—Epirubicin—sarcoma	0.000839	0.000839	CcSEcCtD
Perflutren—Feeling abnormal—Doxorubicin—sarcoma	0.000809	0.000809	CcSEcCtD
Perflutren—Gastrointestinal pain—Doxorubicin—sarcoma	0.000803	0.000803	CcSEcCtD
Perflutren—Hypersensitivity—Epirubicin—sarcoma	0.000782	0.000782	CcSEcCtD
Perflutren—Urticaria—Doxorubicin—sarcoma	0.00078	0.00078	CcSEcCtD
Perflutren—Body temperature increased—Doxorubicin—sarcoma	0.000776	0.000776	CcSEcCtD
Perflutren—Abdominal pain—Doxorubicin—sarcoma	0.000776	0.000776	CcSEcCtD
Perflutren—Asthenia—Epirubicin—sarcoma	0.000762	0.000762	CcSEcCtD
Perflutren—Pruritus—Epirubicin—sarcoma	0.000751	0.000751	CcSEcCtD
Perflutren—Diarrhoea—Epirubicin—sarcoma	0.000726	0.000726	CcSEcCtD
Perflutren—Hypersensitivity—Doxorubicin—sarcoma	0.000724	0.000724	CcSEcCtD
Perflutren—Asthenia—Doxorubicin—sarcoma	0.000705	0.000705	CcSEcCtD
Perflutren—Dizziness—Epirubicin—sarcoma	0.000702	0.000702	CcSEcCtD
Perflutren—Pruritus—Doxorubicin—sarcoma	0.000695	0.000695	CcSEcCtD
Perflutren—Vomiting—Epirubicin—sarcoma	0.000675	0.000675	CcSEcCtD
Perflutren—Diarrhoea—Doxorubicin—sarcoma	0.000672	0.000672	CcSEcCtD
Perflutren—Rash—Epirubicin—sarcoma	0.000669	0.000669	CcSEcCtD
Perflutren—Dermatitis—Epirubicin—sarcoma	0.000669	0.000669	CcSEcCtD
Perflutren—Headache—Epirubicin—sarcoma	0.000665	0.000665	CcSEcCtD
Perflutren—Dizziness—Doxorubicin—sarcoma	0.000649	0.000649	CcSEcCtD
Perflutren—Nausea—Epirubicin—sarcoma	0.00063	0.00063	CcSEcCtD
Perflutren—Vomiting—Doxorubicin—sarcoma	0.000624	0.000624	CcSEcCtD
Perflutren—Rash—Doxorubicin—sarcoma	0.000619	0.000619	CcSEcCtD
Perflutren—Dermatitis—Doxorubicin—sarcoma	0.000619	0.000619	CcSEcCtD
Perflutren—Headache—Doxorubicin—sarcoma	0.000615	0.000615	CcSEcCtD
Perflutren—Nausea—Doxorubicin—sarcoma	0.000583	0.000583	CcSEcCtD
